Evidence map›Paper›PMID 36124498›Full record

ArticleThe Indian journal of medical research

SARS-CoV-2 seropositivity among non-medical frontline workers in Pune, Maharashtra, India.

Avinash R Deoshatwar, Mangesh Damodar Gokhale, Gajanan N Sapkal, Rajlakshmi Viswanathan, Varsha A Potdar, Bipin Tilekar, Laxmi Diliprao Khamankar, Yogesh Krishnarao Gurav, Priya Abraham

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Indian journal of medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Avinash R DeoshatwarEpidemiology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Mangesh Damodar GokhaleEntomology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Gajanan N SapkalDiagnostic Virology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Rajlakshmi ViswanathanBacteriology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Varsha A PotdarNational Influenza Centre, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Bipin TilekarDiagnostic Virology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Laxmi Diliprao KhamankarVirology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Yogesh Krishnarao GuravDengue-Chikungunya Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Priya AbrahamICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Health PersonnelHumansIndia

Identifiers

PMID36124498
PMCPMC9807206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.